DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70748-101 -
Package NDC
70748-101-06 -
Application number
ANDA211579 -
SPL ID
deac53e9-671e-4972-b0fa-9fdf2652a682 -
SPL set ID
e6957674-86c1-4536-8e23-54ad7f2cacc4 -
UNII
1ULL0QJ8UC -
UNII
786Z46389E -
RxCUI
1593058 -
RxCUI
1593068 -
RxCUI
1593070 -
RxCUI
1593072
What the source publishes
- Labeler
- Lupin Pharmaceuticals, Inc.
- Active ingredients
- DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE",
"splId": "deac53e9-671e-4972-b0fa-9fdf2652a682",
"labels": [
{
"setId": "e6957674-86c1-4536-8e23-54ad7f2cacc4",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6957674-86c1-4536-8e23-54ad7f2cacc4",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e6957674-86c1-4536-8e23-54ad7f2cacc4"
}
],
"routes": [
"ORAL"
],
"labeler": "Lupin Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70748-101-06)",
"package_ndc": "70748-101-06",
"identifierStatus": "well-formed",
"marketing_start_date": "20260417"
}
],
"productId": "70748-101_deac53e9-671e-4972-b0fa-9fdf2652a682",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "70748-101",
"deaSchedule": null,
"genericName": "DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DAPAGLIFLOZIN",
"strength": "5 mg/1"
},
{
"name": "METFORMIN HYDROCHLORIDE",
"strength": "500 mg/1"
}
],
"applicationNumber": "ANDA211579",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260417",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000187059",
"N0000187058"
],
"unii": [
"1ULL0QJ8UC",
"786Z46389E"
],
"rxcui": [
"1593058",
"1593068",
"1593070",
"1593072"
],
"spl_set_id": [
"e6957674-86c1-4536-8e23-54ad7f2cacc4"
],
"pharm_class_epc": [
"Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Sodium-Glucose Transporter 2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Lupin Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70748-101_deac53e9-671e-4972-b0fa-9fdf2652a682"